It culminates in the coupling together of factor IX with its cofactor factor VIII to activate factor X. The only currently available anticoagulant used in stroke that acts on the intrinsic pathway is warfarin, which diminishes hepatic synthesis of factor IX as well as prothrombin (factor II) and factor X in the common pathway and factor VII in the extrinsic pathway. This evidence concerns the gene F9 and stroke disorder.